NASDAQ:SRZN

Surrozen Stock Insider Trading

Healthcare > Biotechnology

Buy SRZN

*Your capital is at risk

$24.57

+1.43 (+6.16%)

At Close: Jun 03, 2026

Surrozen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.08. In total, the insiders bought 2.08M and sold 12.49K SRZN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	94.08
● Buy	2.08M shares
● Sell	12.49K shares
94% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence May 04, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 94.08. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 13, 2026 Buy	Option (right to buy) A-Award	Kutzkey Tim	Director	5 550 Value: $167.3K
May 13, 2026 Buy	Director Stock Option (right to buy) A-Award	Berkenblit Anna Director	Director	5 550 Value: $167.3K
May 13, 2026 Buy	Director Stock Option (right to buy) A-Award	Bjerkholt Eric Director	Director	5 550 Value: $167.3K
May 13, 2026 Buy	Director Stock Option (right to buy) A-Award	Chai Christopher Y Director	Director	5 550 Value: $167.3K
May 13, 2026 Buy	Director Stock Option (right to buy) A-Award	Haak-frendscho Mary Director	Director	5 550 Value: $167.3K
May 13, 2026 Buy	Director Stock Option (right to buy) A-Award	Woodhouse David J Director	Director	5 550 Value: $167.3K
May 13, 2026 Buy	Director Stock Option (right to buy) A-Award	Rothenberg Mace Director	Director	5 550 Value: $167.3K
May 04, 2026 Sell	Common Stock S-Sale	Li Yang Exec. Vice President, Research	CEO / President	1 584 Value: $52.8K
May 04, 2026 Sell	Common Stock S-Sale	Williams Charles O Chief Operating Officer	C-Suite Officer	2 036 Value: $67.9K
May 04, 2026 Sell	Common Stock S-Sale	Parker Craig C Chief Executive Officer	CEO / President	4 524 Value: $150.8K
May 01, 2026 Buy	Common Stock M-Exempt	Li Yang Exec. Vice President, Research	CEO / President	4 375 Value: $147.0K
May 01, 2026 Buy	Restricted Stock Unit M-Exempt	Li Yang Exec. Vice President, Research	CEO / President	4 375 Value: $147.0K
May 01, 2026 Buy	Common Stock M-Exempt	Williams Charles O Chief Operating Officer	C-Suite Officer	5 625 Value: $189.0K
May 01, 2026 Buy	Restricted Stock Unit M-Exempt	Williams Charles O Chief Operating Officer	C-Suite Officer	5 625 Value: $189.0K
May 01, 2026 Buy	Common Stock M-Exempt	Parker Craig C Chief Executive Officer	CEO / President	12 500 Value: $420.0K
May 01, 2026 Buy	Restricted Stock Unit M-Exempt	Parker Craig C Chief Executive Officer	CEO / President	12 500 Value: $420.0K
Mar 31, 2026 Sell	Common Stock G-Gift	Li Yang Exec. Vice President, Research	CEO / President	1 666 Value: $0
Mar 24, 2026 Buy	Common Stock P-Purchase	Tcg Crossover Gp Ii, Llc 10 Percent Owner	10% Owner	53 329 Value: $1.32M
Mar 24, 2026 Buy	Common Stock P-Purchase	Tcg Crossover Gp Ii, Llc 10 Percent Owner	10% Owner	53 329 Value: $1.32M
Mar 23, 2026 Buy	Common Stock P-Purchase	Tcg Crossover Gp Ii, Llc 10 Percent Owner	10% Owner	7 611 Value: $189.5K
Mar 23, 2026 Buy	Common Stock P-Purchase	Tcg Crossover Gp Ii, Llc 10 Percent Owner	10% Owner	7 612 Value: $189.5K
Mar 16, 2026 Buy	Common Stock P-Purchase	Tcg Crossover Gp Ii, Llc 10 Percent Owner	10% Owner	595 Value: $14.9K
Mar 16, 2026 Buy	Common Stock P-Purchase	Tcg Crossover Gp Ii, Llc 10 Percent Owner	10% Owner	595 Value: $14.9K
Mar 13, 2026 Buy	Common Stock P-Purchase	Tcg Crossover Gp Ii, Llc 10 Percent Owner	10% Owner	17 716 Value: $440.7K
Mar 13, 2026 Buy	Common Stock P-Purchase	Tcg Crossover Gp Ii, Llc 10 Percent Owner	10% Owner	17 717 Value: $440.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SURROZEN, INC.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic...

Read Full Profile Here